Cargando…

NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity

Antibodies acquired naturally through repeated exposure to Plasmodium falciparum are essential in the control of blood-stage malaria. Antibody-dependent functions may include neutralization of parasite–host interactions, complement activation, and activation of Fc receptor functions. A role of antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Gunjan, Hart, Geoffrey T, Manzella-Lapeira, Javier, Doritchamou, Justin YA, Narum, David L, Thomas, L Michael, Brzostowski, Joseph, Rajagopalan, Sumati, Doumbo, Ogobara K, Traore, Boubacar, Miller, Louis H, Pierce, Susan K, Duffy, Patrick E, Crompton, Peter D, Desai, Sanjay A, Long, Eric O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019063/
https://www.ncbi.nlm.nih.gov/pubmed/29943728
http://dx.doi.org/10.7554/eLife.36806
Descripción
Sumario:Antibodies acquired naturally through repeated exposure to Plasmodium falciparum are essential in the control of blood-stage malaria. Antibody-dependent functions may include neutralization of parasite–host interactions, complement activation, and activation of Fc receptor functions. A role of antibody-dependent cellular cytotoxicity (ADCC) by natural killer (NK) cells in protection from malaria has not been established. Here we show that IgG isolated from adults living in a malaria-endemic region activated ADCC by primary human NK cells, which lysed infected red blood cells (RBCs) and inhibited parasite growth in an in vitro assay for ADCC-dependent growth inhibition. RBC lysis by NK cells was highly selective for infected RBCs in a mixed culture with uninfected RBCs. Human antibodies to P. falciparum antigens PfEMP1 and RIFIN were sufficient to promote NK-dependent growth inhibition. As these results implicate acquired immunity through NK-mediated ADCC, antibody-based vaccines that target bloodstream parasites should consider this new mechanism of action.